Keyword: Biotechnology

News

J&J Clinches Actelion for $30 Billion

27.01.2017 - Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...

News

Silence Buys Into Arrowhead Pharmaceuticals

16.01.2017 - UK-based Silence Therapeutics has acquired an 8.4% equity stake in US biotech group Arrowhead Pharmaceuticals to potentially advance progress in novel RNA therapeutics. Silence...

News

J&J and Actelion Said Talking to Swiss Regulators

09.01.2017 - Actelion and Johnson & Johnson may be edging closer to a deal that would give the US healthcare giant at least a major chunk of the Swiss biotech firm, according to the Zurich...

News

Amyris and Nikkol in Cosmetic Ingredients Pact

21.12.2016 - US renewables company Amyris has signed an agreement with Japan’s Nikkol Group to form a cosmetic ingredients joint venture. Under the terms of the proposal, Nikkol will purchase...

News

Johnson & Johnson Quits Actelion Bid

15.12.2016 - Johnson & Johnson has withdrawn from the running for Actelion Pharmaceuticals, leaving the path clear for another buyer, which multiple reports say is Sanofi. The US healthcare...

News

AstraZeneca and Bicycle Therapeutics in Peptides Pact

05.12.2016 - Anglo-Swedish drugmaker AstraZeneca is collaborating with Bicycle Therapeutics to develop a novel class of small-molecule medicines for treating respiratory, cardiovascular and...

News

Evonik Buys Metabolic’s Methionine Portfolio

02.12.2016 - Evonik has agreed to buy Metabolic Explorer’s methionine technology portfolio for €45 million. The deal, signed on Nov. 28, strengthens the Essen-based specialty chemical company’s...

Sites & Services

Chemistry Works – at Every Level

21.11.2016 - More than 12,000 foreign companies have already chosen Hesse as the place to do business. A clear commitment to Europe’s most central location. Across all industries, employers...